These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 10375614)
1. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast. Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614 [TBL] [Abstract][Full Text] [Related]
2. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma. Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894 [TBL] [Abstract][Full Text] [Related]
4. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181 [TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia. Saed GM; Collins KL; Diamond MP Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer. Guo Y; Jacobs SC; Kyprianou N Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856 [TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor (TGF)-beta1, TGF-beta2, and TGF-beta3 and of type I and II TGF-beta receptors during the development of the human fetal ovary. Schilling B; Yeh J Fertil Steril; 1999 Jul; 72(1):147-53. PubMed ID: 10428164 [TBL] [Abstract][Full Text] [Related]
10. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Horner A; Kemp P; Summers C; Bord S; Bishop NJ; Kelsall AW; Coleman N; Compston JE Bone; 1998 Aug; 23(2):95-102. PubMed ID: 9701467 [TBL] [Abstract][Full Text] [Related]
11. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia. Vivien D; Bernaudin M; Buisson A; Divoux D; MacKenzie ET; Nouvelot A J Neurochem; 1998 Jun; 70(6):2296-304. PubMed ID: 9603194 [TBL] [Abstract][Full Text] [Related]
12. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells. Zhang H; Shaw AR; Mak A; Letarte M J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807 [TBL] [Abstract][Full Text] [Related]
13. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury. Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216 [TBL] [Abstract][Full Text] [Related]
16. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Kassem M; Kveiborg M; Eriksen EF Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L; Malentacchi C; Campanacci D; Franchi A Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma. Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633 [TBL] [Abstract][Full Text] [Related]
19. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis. Jakowlew SB; Moody TW; You L; Mariano JM Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100 [TBL] [Abstract][Full Text] [Related]
20. Expression of TGF-beta related Smad proteins in human epithelial skin tumors. Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]